← Leaderboards
Katelyn E Swindle-Reilly
Ohio State University
$2,351,218
Attributed
$2,351,218
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $946.3K · FY2022–25$1M$750K$500K$250K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$2,351,218 · 3
By mechanism
R01$1,558,800 · 1
R21$792,418 · 2
Top collaborators
No co-investigators on record.
Most similar at Ohio State University
Same institution · by research overlap
- Matthew A Reilly$1,129,698
- Ly James Lee$3,875,706
- Ouliana Ziouzenkova Ziouzenkova$418,900
- Scott R Schricker$996,229
- Noriko Katsube$506,886
Others in their field
Other Rising Stars on “Cells”
- Mari Ostendorf · University Of Washington$51,931,230
- Sabrina Paganoni · Massachusetts General Hospital$30,122,905
- Suma Babu · Massachusetts General Hospital$30,122,905
- Supriya Menezes · The Emmes Company, Llc$25,277,032
- Jinsy Andrews · Columbia University Health Sciences$21,294,649
- Michelle Rives · Baylor College Of Medicine$20,650,593
Research focus
CellsPreventVisionIn VitroTissuesAffectInjectableInjectionsIn VivoEye DiseasesFrequenciesInflammationInflammatory MarkerCostExperimental StudyInnovationCapsuleAnti-Inflammatory AgentsBiomaterial CompatibilityAge Related Macular DegenerationBarrier To CareEnzyme-Linked Immunosorbent AssayDisease ProgressionAdverse Event Risk
Grant awards (7)
Predictive Drug Release from a Tunable Injectable Capsule$496,207
R01 · FY2025 · EB · contact PI
Predictive Drug Release from a Tunable Injectable Capsule$489,858
R01 · FY2024 · EB · contact PI
Evaluation of New Anti-inflammatory Treatments for Age-Related Macular Degeneration$236,250
R21 · FY2024 · EY · contact PI
Predictive Drug Release from a Tunable Injectable Capsule$572,735
R01 · FY2023 · EB · contact PI
Lens Epithelial Cell Response to Biomaterial Interfaces$221,141
R21 · FY2023 · EY · contact PI
Evaluation of New Anti-inflammatory Treatments for Age-Related Macular Degeneration$152,405
R21 · FY2023 · EY · contact PI
Lens Epithelial Cell Response to Biomaterial Interfaces$182,622
R21 · FY2022 · EY · contact PI